pindolol has been researched along with alanine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
| Barak, LS; Caron, MG; Freedman, NJ; Kwatra, MM; Lefkowitz, RJ; Tiberi, M | 1 |
| Gabilondo, AM; Krasel, C; Lohse, MJ | 1 |
| Lin, A; Maes, M; Scharpé, S; Vandoolaeghe, E; Verkerk, R | 1 |
| Clark, RB; Dai, W; Friedman, J; Godines, V; Knoll, BJ; Millman, EE; Moore, RH; Tran, TM; Vaughan, DJ | 1 |
1 trial(s) available for pindolol and alanine
| Article | Year |
|---|---|
Serum levels of excitatory amino acids, serine, glycine, histidine, threonine, taurine, alanine and arginine in treatment-resistant depression: modulation by treatment with antidepressants and prediction of clinical responsivity.
Topics: Adult; Aged; Alanine; Antidepressive Agents; Antidepressive Agents, Tricyclic; Arginine; Asparagine; Aspartic Acid; Depressive Disorder, Major; Drug Resistance; Drug Therapy, Combination; Excitatory Amino Acids; Female; Fluoxetine; Glycine; Histidine; Humans; Male; Middle Aged; Personality Inventory; Pindolol; Prognosis; Selective Serotonin Reuptake Inhibitors; Serine; Taurine; Threonine; Trazodone; Treatment Outcome | 1998 |
4 other study(ies) available for pindolol and alanine
| Article | Year |
|---|---|
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
A highly conserved tyrosine residue in G protein-coupled receptors is required for agonist-mediated beta 2-adrenergic receptor sequestration.
Topics: Alanine; Amino Acid Sequence; Animals; CHO Cells; Conserved Sequence; Cricetinae; Down-Regulation; Epitopes; GTP-Binding Proteins; Humans; Iodocyanopindolol; Isoproterenol; Kinetics; Molecular Sequence Data; Multigene Family; Mutagenesis, Site-Directed; Pindolol; Polymerase Chain Reaction; Protein Conformation; Radioligand Assay; Receptors, Adrenergic, beta-2; Receptors, Cell Surface; Sequence Homology, Amino Acid; Transfection; Tyrosine | 1994 |
Mutations of Tyr326 in the beta 2-adrenoceptor disrupt multiple receptor functions.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Alanine; Animals; Cell Membrane; CHO Cells; Cloning, Molecular; Cricetinae; Gene Expression; Humans; Iodine Radioisotopes; Isoproterenol; Mutagenesis, Site-Directed; Mutation; Phenylalanine; Pindolol; Protein Binding; Radioligand Assay; Receptors, Adrenergic, beta-2; Transfection; Tyrosine | 1996 |
Role of the G protein-coupled receptor kinase site serine cluster in beta2-adrenergic receptor internalization, desensitization, and beta-arrestin translocation.
Topics: Adenylyl Cyclases; Alanine; Arrestins; Aspartic Acid; beta-Arrestin 1; beta-Arrestin 2; beta-Arrestins; Binding Sites; Blotting, Western; Cell Line; Cell Membrane; Cyclic AMP-Dependent Protein Kinases; DNA, Complementary; Epinephrine; G-Protein-Coupled Receptor Kinase 1; Green Fluorescent Proteins; Humans; Isoproterenol; Kinetics; Mutation; Phosphorylation; Pindolol; Protein Structure, Tertiary; Protein Transport; Receptors, Adrenergic, beta-2; Serine; Time Factors; Transfection | 2006 |